FDA Hears Results of Two Different Off-Label Surveys of Consumers at Recent Public Hearing

At the recent Part 15 FDA hearing on off-label promotion (seehere) results from two different consumer/patient surveys were presented. The first was presented by John Mack (i.e., me), Editor ofPharma Marketing News (PMN) and the second was presented by Dr. Doris Peter, Principal Investigator, Best Buy Drugs Project at Consumer Reports (CR).The PMN survey was administered byinVibe Research, which collects responses via automated, voice-response surveys. Fifty-on respondents were reached via a network of patient community partnerships. These included 40 patient advocates, 20 chronic condition patients (diabetes, fibromyalgia, arthritis, CHF, etc.), and 9 caregivers.The Consumer Reports survey was done by random-digit dialing so that the 1,011 survey respondents are"demographically and geographically representative of the U.S. population."Thus, an important difference between these surveys is the first is patient& patient advocate specific whereas the second is generally consumer specific.Let's compare the results of these two surveys.Read more »
Source: Pharma Marketing Blog - Category: Pharmaceuticals Tags: Consumer Reports FDA off-label promotion Patient Advocacy Source Type: blogs